Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INSULIN GLARGINE Cause Paralysis? 84 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Paralysis have been filed in association with INSULIN GLARGINE (Lantus Solostar). This represents 0.1% of all adverse event reports for INSULIN GLARGINE.

84
Reports of Paralysis with INSULIN GLARGINE
0.1%
of all INSULIN GLARGINE reports
3
Deaths
19
Hospitalizations

How Dangerous Is Paralysis From INSULIN GLARGINE?

Of the 84 reports, 3 (3.6%) resulted in death, 19 (22.6%) required hospitalization, and 2 (2.4%) were considered life-threatening.

Is Paralysis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INSULIN GLARGINE. However, 84 reports have been filed with the FAERS database.

What Other Side Effects Does INSULIN GLARGINE Cause?

Blood glucose increased (19,234) Inappropriate schedule of product administration (8,982) Product storage error (7,743) Off label use (6,842) Visual impairment (5,793) Blood glucose decreased (4,552) Drug ineffective (4,351) Hypoglycaemia (4,212) Injection site pain (3,574) Device issue (3,175)

What Other Drugs Cause Paralysis?

ADALIMUMAB (275) INTERFERON BETA-1A (181) METHOTREXATE (181) PREGABALIN (171) RITUXIMAB (166) ATORVASTATIN (160) DIMETHYL (156) FINGOLIMOD (145) NATALIZUMAB (136) ETANERCEPT (134)

Which INSULIN GLARGINE Alternatives Have Lower Paralysis Risk?

INSULIN GLARGINE vs INSULIN GLARGINE-YFGN INSULIN GLARGINE vs INSULIN GLARGINE\LIXISENATIDE INSULIN GLARGINE vs INSULIN GLULISINE INSULIN GLARGINE vs INSULIN HUMAN INSULIN GLARGINE vs INSULIN LISPRO

Related Pages

INSULIN GLARGINE Full Profile All Paralysis Reports All Drugs Causing Paralysis INSULIN GLARGINE Demographics